Cargando…
Compassionate use and hospital exemption for regenerative medicine: Something wrong to apply the program for patients in a real world
“Compassionate use” or “Hospital exemption” provides an important pathway for patients with life-threatening conditions to gain access to unproved human cells and tissue products. In a real world, any practitioners may not comply with relevant system. Such regulation should establish an internationa...
Autores principales: | Yano, Kazuo, Yamato, Masayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society for Regenerative Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6146111/ https://www.ncbi.nlm.nih.gov/pubmed/30271867 http://dx.doi.org/10.1016/j.reth.2018.03.002 |
Ejemplares similares
-
Commentary: If it's difficult, we are doing something wrong
por: Shah, Ashish S.
Publicado: (2021) -
Expedited approval system for regenerative medicine products – Is it unusual?
por: Yano, Kazuo, et al.
Publicado: (2016) -
Compassionate use of drugs and medical devices in the United States, the European Union and Japan
por: Tsuyuki, Kenichiro, et al.
Publicado: (2016) -
There is something wrong but where? Dislocation or fracture?
por: Karslıoglu, Bulent, et al.
Publicado: (2015) -
Comparison of the new Japanese legislation for expedited approval of regenerative medicine products with the existing systems in the USA and European Union
por: Jokura, Yoji, et al.
Publicado: (2017)